BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22798127)

  • 1. Myocarditis due to mesalamine treatment in a patient with Crohn's disease in China.
    Liu Y; Ye J; Zhu J; Chen W; Sun Y
    Turk J Gastroenterol; 2012 Jun; 23(3):304-6. PubMed ID: 22798127
    [No Abstract]   [Full Text] [Related]  

  • 2. Mesalamine-induced myocarditis following diagnosis of Crohn's disease: a case report.
    Galvão Braga C; Martins J; Arantes C; Ramos V; Vieira C; Salgado A; Magalhães S; Correia A
    Rev Port Cardiol; 2013 Sep; 32(9):717-20. PubMed ID: 23993290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocarditis by mesalazine with cardiac magnetic resonance imaging.
    García-Ferrer L; Estornell J; Palanca V
    Eur Heart J; 2009 Apr; 30(8):1015. PubMed ID: 19168869
    [No Abstract]   [Full Text] [Related]  

  • 4. Mesalamine-induced myopericarditis in a paediatric patient with Crohn's disease.
    Nair AG; Cross RR
    Cardiol Young; 2015 Apr; 25(4):783-6. PubMed ID: 24915235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac MRI-confirmed mesalamine-induced myocarditis.
    Baker WL; Saulsberry WJ; Elliott K; Parker MW
    BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26341161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesalazine-induced myopericarditis in a patient with ulcerative colitis.
    Doganay L; Akinci B; Pekel N; Simsek I; Akpinar H
    Int J Colorectal Dis; 2006 Mar; 21(2):199-200. PubMed ID: 15726390
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pancreatitis in a patient with Crohn disease treated with mesalazine and azathioprine].
    Glintborg B
    Ugeskr Laeger; 2000 Aug; 162(34):4553-4. PubMed ID: 10981226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desensitization treatment of an aspirin- and mesalamine-sensitive patient with Crohn's disease.
    Paraskevopoulos I; Konstantinou G; Liatsos C
    Inflamm Bowel Dis; 2005 Apr; 11(4):417-8. PubMed ID: 15803034
    [No Abstract]   [Full Text] [Related]  

  • 9. Mesalamine-associated hypersensitivity myocarditis in ulcerative colitis.
    Stelts S; Taylor MH; Nappi J; Van Bakel AB
    Ann Pharmacother; 2008 Jun; 42(6):904-5. PubMed ID: 18430794
    [No Abstract]   [Full Text] [Related]  

  • 10. Concurrent Sweet's syndrome and myopericarditis following mesalamine therapy.
    Shabtaie SA; Tan NY; Parikh RS; Papadakis KA
    BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29574433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma N-terminal pro-B-type natriuretic peptide (BNP) in mesalazine-induced myopericarditis.
    Paschalis T; Paschali M; Mandal AKJ; Missouris CG
    BMJ Case Rep; 2019 Apr; 12(4):. PubMed ID: 30975785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesalazine-induced Pleuropericarditis in a Patient with Crohn's Disease.
    Kiyomatsu H; Kawai K; Tanaka T; Tanaka J; Kiyomatsu T; Nozawa H; Kanazawa T; Kazama S; Ishihara S; Yamaguchi H; Sunami E; Watanabe T
    Intern Med; 2015; 54(13):1605-8. PubMed ID: 26134190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Angioedema in Crohn's disease possibly due to mesalazine].
    Nguyen-Khac E; Le Baron F; Thevenot T; Tiry-Lescut C; Tiry F
    Gastroenterol Clin Biol; 2002 May; 26(5):535-6. PubMed ID: 12122371
    [No Abstract]   [Full Text] [Related]  

  • 14. [Acute pleuropericarditis in a patient with Crohn's disease controlled with chronic therapy with mesalazine].
    Merino Rivas JL; Arambarri Segura M; Quereda Rodríguez-Navarro C; Dronda Núñez F
    Rev Clin Esp; 2002 Feb; 202(2):122-3. PubMed ID: 11996772
    [No Abstract]   [Full Text] [Related]  

  • 15. Recurrence of myocarditis after mesalazine treatment for ulcerative colitis: a case report.
    Sabatini T; Filippini A; Nicosia F; Preti S; Bertoli M
    Inflamm Bowel Dis; 2013 Mar; 19(3):E46-8. PubMed ID: 22517473
    [No Abstract]   [Full Text] [Related]  

  • 16. Pericarditis associated with longstanding mesalazine administration in a patient.
    Vayre F; Vayre-Oundjian L; Monsuez JJ
    Int J Cardiol; 1999 Feb; 68(2):243-5. PubMed ID: 10189017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial nephritis in children with Crohn's disease.
    Benador N; Grimm P; Lemire J; Griswold W; Billman G; Reznik V
    Clin Pediatr (Phila); 2000 Apr; 39(4):253-4. PubMed ID: 10791141
    [No Abstract]   [Full Text] [Related]  

  • 18. [Consequences of galenic differences and outcome of clinical trials with budesonide and 5-aminosalicylic acids for therapy of Crohn disease].
    Stange EF
    Med Klin (Munich); 1999 Feb; 94 Suppl 1():39-41. PubMed ID: 10194947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical effects of 5-aminosalicylic acid preparations in Crohn disease].
    Fleig WE
    Med Klin (Munich); 1999 Feb; 94 Suppl 1():22-5. PubMed ID: 10194944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe myalgia associated with mesalazine treatment in a child with Crohn's disease.
    Persić M; Palcevski G; Slavić I; Vlahović-Palcevski V
    Eur J Clin Pharmacol; 2007 Mar; 63(3):315-7. PubMed ID: 17242922
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.